Open label trial for efficacy and safety of Hydroxychloroquine for systemic lupus erythematosus
Not Applicable
Recruiting
- Conditions
- systemic lupus erythematosus cutaneous lupus erythematosus
- Registration Number
- JPRN-UMIN000012478
- Lead Sponsor
- Department of Internal Medicine, Teikyo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe insufficiency in liver, kidney, heart, bone marrow function. Patients with current or previous history of retinopathy. Patients allergic to 4-aminoquinoline. Other patients who were judged to be ineligible for the study by an attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method